Patent · US Active

Method of prognosis and follow up of primary liver cancer

US12360113B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignees

Inventor

Key dates

Filing dateOct 15, 2018
Grant dateJul 15, 2025
Priority date
Expiry dateNov 23, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to new methods for assessing the risk of a patient, in particular with chronic liver disease, to develop primary liver cancer over time, using functions combining blood biochemical markers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.